The proportion of patients observed in a COVID-19 emergency setting for more than 6 h or transferred to a teritary hospital due to COVID-19 was lower for the fluvoxamine group compared with placebo (79 [11%] of 741 vs 119 [16%] of 756);
Interpretation
Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital.
Not bad, not a magic bullet, but reducing hospitalization rates from 16% to 11% is a win.
This is not a meme cure based on sketchy research. It appeared to be effective in a recent study in Brazil with 3,000 experiment participants (admittedly not enough, but more research is underway) and it has been covered extensively by mainstream (i.e., not totally crazy) news outlets.
By comparison, I recall that some of the studies that championed ivermectin as a treatment for COVID included experiment participants who were dead before the studies began.
Almost all drugs are tested in animals before humans. There's a huge overlap between "horse drugs" and "human drugs" (et cetera -- a snake of mine got infected by mites, and they don't make snake drugs, so the vet gave us drugs "made for rodents.") While certain drugs have been politicized, and that's bad, your comment is little more than an association fallacy driven by that same polarization. Please don't.
Interpretation Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital.
Not bad, not a magic bullet, but reducing hospitalization rates from 16% to 11% is a win.